e-learning resources

Annual Congress Vienna 2003

Saturday, 27.09.2003
Sunday, 28.09.2003
Monday, 29.09.2003
Tuesday, 30.09.2003
Wednesday, 01.10.2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

3196 Abstracts
374 Slide presentations

Material from 2003: Show

Pathophysiology of the pulmonary circulation

Oral Presentation
Chairs: R. Naeije (Brussels, Belgium), S. Adnot (Creteil, France)

Download all media

Download all media

Incomplete gas-exchange resolution after liver transplantation in hepatopulmonary syndrome F. P. Gómez, G. Martinez-Pallí, J. C. García-Valdecasas, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain)
Endothelin-1 in patients with the hepatopulmonary syndrome P. Schenk, V. Fuhrmann, M. Schoeniger-Hekele, C. Mueller, O. F. Wagner (Vienna, Austria)
Hepatopulmonary syndrome is associated with bacterial translocation in cirrhotic rats B. Sztrymf, D. Lebrec, M. Mazmanian, P. Herve (Le Plessis Robinson, Clichy, France)
Overexpression of serotonin receptor 1B (5HT-1B) responsible for overflow induced experimental pulmonary arterial hypertension development B. Rondelet, F. Kerbaul, S. Motte, R. Van Beneden, K. Jean-Marie, R. Naeije (Brussels, Belgium)
Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD T. Melgosa, V. Peinado, S. Santos, J. Morales, J. Ramirez, J. Roca, R. Rodriguez-Roisin, J. Barbera (Barcelona, Spain)
Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive lung disease S. Eddahibi, A. Chaouat, N. Morrell, E. Fadel, C. Fuhrman, P. Dartevelle, B. Housset, M. Hamon, E. Weitzenblum, S. Adnot (Créteil, France)
Model-based combination of pressure and flow: a framework for differential diagnosis of pulmonary hypertension J. W. Lankhaar, T. J. Faes, R. J. Roeleveld, J. T. Marcus, N. Westerhof, A. Vonk Noordegraaf (Amsterdam, The Netherlands)
Effects of iloprost and the phosphodiesterase inhibitor tolafentrine on pulmonary vascular remodelling in chronic experimental pulmonary hypertension R. T. Schermuly, K. P. Kreisselmeier, A. Ghofrani, N. Weissmann, F. Rose, C. Schudt, W. Seeger, F. Grimminger (Giessen, Konstanz, Germany)

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.